Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitiligo: a new classification and therapy

M Koga

    The British Journal of Dermatology
    |September 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Vitiligo research distinguishes between two types: dermatomally distributed vitiligo (Type B) linked to sympathetic nerve dysfunction and non-dermatomally distributed vitiligo (Type A) possibly involving melanocyte autoimmunity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Retrieval and cryopreservation of testicular sperm].

    Hinyokika kiyo. Acta urologica Japonica·2000
    Same author

    Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.

    Hypertension research : official journal of the Japanese Society of Hypertension·2000
    Same author

    A Caenorhabditis elegans MAP kinase kinase, MEK-1, is involved in stress responses.

    The EMBO journal·2000
    Same author

    Cloning and characterization of a complementary deoxyribonucleic acid encoding haploid-specific alanine-rich acidic protein located on chromosome-X.

    Biology of reproduction·2000
    Same author

    The relationship between angioblastoma (Nakagawa) and tufted angioma: report of four cases with angioblastoma and a literature-based comparison of the two conditions.

    The Journal of dermatology·2000
    Same author

    CD14+CD16+ monocyte subpopulation in Kawasaki disease.

    Clinical and experimental immunology·2000
    Same journal

    Biett's Sign: A Diagnostic Clue to Secondary Syphilis.

    The British journal of dermatology·2026
    Same journal

    Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.

    The British journal of dermatology·2026
    Same journal

    Management Patterns and Repigmentation Outcomes in Pediatric Segmental Versus Non-segmental Vitiligo: A Single-center Retrospective Study (2015-2024).

    The British journal of dermatology·2026
    Same journal

    Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.

    The British journal of dermatology·2026
    Same journal

    Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

    The British journal of dermatology·2026
    Same journal

    Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

    The British journal of dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Immunology
    • Neurology

    Background:

    • Vitiligo is a condition causing skin depigmentation.
    • Existing research suggests varied underlying mechanisms for different vitiligo presentations.

    Purpose of the Study:

    • To investigate the distinct pathophysiological mechanisms of dermatomally versus non-dermatomally distributed vitiligo.
    • To propose a classification system based on these findings.

    Main Methods:

    • Local physostigmine injections were used to assess sympathetic nerve function in affected skin.
    • Therapeutic responses to topical corticosteroids and oral nialamide were evaluated.

    Main Results:

    • Dermatomally distributed vitiligo showed sympathetic nerve dysfunction in affected skin.

    Related Experiment Videos

  • Non-dermatomally distributed vitiligo did not exhibit this nerve dysfunction.
  • Topical corticosteroids were effective for non-dermatomally distributed vitiligo (Type A), while oral nialamide benefited dermatomally distributed vitiligo (Type B).

    • Conclusions:

    • Dermatomally distributed vitiligo (Type B) is hypothesized to stem from sympathetic nerve dysfunction.
    • Non-dermatomally distributed vitiligo (Type A) is suspected to involve autoimmune mechanisms affecting melanocytes.
    • The proposed classification differentiates vitiligo subtypes based on distinct etiologies and treatment responses.